News Focus
News Focus
icon url

oc631

02/15/14 12:42 AM

#174266 RE: oc631 #174265

GILD stands to lose many GT3 patients to the Sovaldi/Daclatasvir combination if approved.





Edit: Gild stands to lose many higher margin GT3 patients to the Sovaldi/Daclatasvir combination if approved.